CIK 0001641489 · Non-accelerated filer<br>Smaller reporting company
vTv Therapeutics Inc.
Sign in to watch- Ticker
- VTVT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473916571
- Phone
- 336-841-0300
- Business address
- 3980 PREMIER DR, SUITE 310, HIGH POINT, NC, 27265
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Results of operations
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 4 Open-market buy Director bought 6,000 shares at $5.67 ($34,028)
- 4 Open-market buy Director bought 1,259 shares at an average $5.26 ($6,618)
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Unregistered share sale
- 4 Open-market buy 10% owner bought 10,000 shares at $4.99 ($49,906)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 400,000 shares at an average $5.20 ($2,079,960)
- 4 Open-market buy Director bought 10,000 shares at an average $5.35 ($53,450)
- 4 Open-market buy 10% owner bought 10,000 shares at $5.64 ($56,438)
- DEFA14A Proxy Proxy Materials
Page 26 of 31 · 602 filings